BLFSBIOLIFE SOLUTIONS INC

Nasdaq biolifesolutions.com


$ 17.83 $ 0.33 (1.88 %)    

Monday, 29-Apr-2024 15:59:54 EDT
QQQ $ 433.04 $ 1.75 (0.41 %)
DIA $ 383.81 $ 1.49 (0.39 %)
SPY $ 510.06 $ 1.80 (0.35 %)
TLT $ 88.99 $ 0.74 (0.84 %)
GLD $ 216.18 $ -0.44 (-0.2 %)
$ 17.86
$ 17.99
$ 17.84 x 200
$ 0.00 x 0
$ 17.81 - $ 18.20
$ 8.92 - $ 24.50
386,461
na
780.82M
$ 1.55
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-29-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-09-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 03-31-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 03-31-2021 12-31-2020 10-K
14 11-09-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-29-2020 03-31-2020 10-Q
17 05-15-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-09-2019 06-30-2019 10-Q
20 05-09-2019 03-31-2019 10-Q
21 03-15-2019 12-31-2018 10-K
22 11-08-2018 09-30-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
24 05-11-2018 03-31-2018 10-Q
25 03-09-2018 12-31-2017 10-K
26 11-09-2017 09-30-2017 10-Q
27 08-11-2017 06-30-2017 10-Q
28 05-12-2017 03-31-2017 10-Q
29 03-15-2017 12-31-2016 10-K
30 11-10-2016 09-30-2016 10-Q
31 08-11-2016 06-30-2016 10-Q
32 05-16-2016 03-31-2016 10-Q
33 02-25-2016 12-31-2015 10-K
34 11-12-2015 09-30-2015 10-Q
35 08-06-2015 06-30-2015 10-Q
36 05-07-2015 03-31-2015 10-Q
37 03-12-2015 01-31-2015 10-K
38 11-06-2014 09-30-2014 10-Q
39 08-07-2014 06-30-2014 10-Q
40 05-08-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jefferies-initiates-coverage-on-biolife-solns-with-buy-rating-announces-price-target-of-22

Jefferies analyst Matthew Stanton initiates coverage on BioLife Solns (NASDAQ:BLFS) with a Buy rating and announces Price Ta...

 recap-biolife-solns-q4-earnings
Recap: BioLife Solns Q4 Earnings
02/29/2024 21:10:54

 biolife-solns-q4-2023-adj-eps-0210-beats-0340-estimate-sales-32732m-miss-33399m-estimate

BioLife Solns (NASDAQ:BLFS) reported quarterly losses of $(0.210) per share which beat the analyst consensus estimate of $(0.34...

 earnings-scheduled-for-february-29-2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

 earnings-scheduled-for-november-9-2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

 over-1m-bet-on-carnival-check-out-these-3-stocks-insiders-are-buying

Although U.S. stocks closed mixed on Monday, there were a few notable insider trades.

 top-5-health-care-stocks-that-could-blast-off-this-month

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 stocks-that-hit-52-week-lows-on-friday

  During the Friday's sesion, 157 stocks hit new 52-week lows.

 craig-hallum-maintains-buy-on-biolife-solns-lowers-price-target-to-23

Craig-Hallum analyst Matt Hewitt maintains BioLife Solns (NASDAQ:BLFS) with a Buy and lowers the price target from $29 to $23.

 stocks-that-hit-52-week-lows-on-thursday

  On Thursday, 128 companies set new 52-week lows.

 td-cowen-maintains-outperform-on-biolife-solns-lowers-price-target-to-25

TD Cowen analyst Max Masucci maintains BioLife Solns (NASDAQ:BLFS) with a Outperform and lowers the price target from $29 to...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION